Sweden· SE-20220304000016
Pyridostigmin Orifarm 60 mg Dragerad tablett
A pyridostigmine product containing pyridostigmine bromide, registered in Sweden by Orifarm Healthcare A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Pyridostigmine is registered in 16 of 19 countries.
Countries holding a registration under ATC N07AA02 (pyridostigmine), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Pyridostigmine · ATC N07AA02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pyridostigmine costs, country by country.
Normalised to the WHO defined daily dose (0.18 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pyridostigmine · price per daily dose (0.18 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.06
- FR France$1.63
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Pyridostigmine Bromide
- Manufacturer
- Orifarm Healthcare A/S
- Country
- Sweden (SE)
- ATC code
- N07AA02
- ATC class
- Pyridostigmine
- Defined daily dose
- 0.18 g, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20220304000016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for pyridostigmine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pyridostigmine · interactions on record
106 records
- 2 severe
- 56 moderate
- 48 info
Most severe, free to view
- SiponimodL04AA42severe
- SiponimodL04AE03severe
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pyridostigmine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandMestinonViatris Healthcare Sp. z o.o.
- NorwayMestinon2care4 ApS
- United KingdomMestinon 60mg tabletsLexon (UK) Ltd
- United StatesMestinonBausch Health US, LLC
- GermanyAmindanDesitin Arzneimittel Gmbh
- CzechiaMESTINONMylan IRE Healthcare Limited, Dublin
- SwitzerlandMestinon retard, TablettenMEDA Pharmaceuticals Switzerland GmbH
- CanadaJAMP PYRIDOSTIGMINE BROMIDEJAMP PHARMA CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Mestinon
- Belgium · Mestinon
- Bulgaria · Калимин
- Czechia · Mestinon
- Germany · Amindan, Kalymin
- Denmark · Mestinon, Pyridostigminbromid Orifarm
- Estonia · Kalymin, Mestinon
- Spain · Mestinon
- Finland · Mestinon
- France · Mestinon, Mestinon Lp
- United Kingdom (Northern Ireland) · Mestinon, Pyridostigmine Bromide
- Greece · Mestinon
- Croatia · Mestinon 60
- Hungary · Mestinon
- Ireland · Mestinon
- Italy · Mestinon
- Luxembourg · Mestinon
- Latvia · Kalymin 60 N, Mestinon
- Malta · Mestinon
- Netherlands · Mestinon, Mestinon 60
- Norway · Mestinon
- Poland · Mestinon, Stygmistanon
- Portugal · Mestinon
- Romania · Mestinon
- Slovenia · Mestinon
- Slovakia · Mestinon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07a9eeaf-6390-4ebe-8fa1-2df770420229 GET /v1/drugs/07a9eeaf-6390-4ebe-8fa1-2df770420229?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"PL",
"SmPC"
],
"se_npl_id": "20220304000016",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220304000016",
"product_doc_link": "https://docetp.mpa.se/LMF/Pyridostigmin%20Orifarm%20coated%20tablet%20SmPC_09001bee8325e802.pdf"
}See everything about pyridostigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.